facebook

2nd Annual EU Medical Device Post-Market Clinical Evaluation Planning Conference

October 6-7, 2020 | Brussels, Belgium

2nd Annual EU Medical Device Post-Market Clinical Evaluation Planning Conference
October 6-7, 2020 | Brussels, Belgium

Request Invite

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

“I thought the conference was excellent!  Having a conference tailored to one discipline made each panel and contact relevant.”

Director, Compliance & Legal Affairs
Orexigen

“Great insight to hear payer perspective in contracting and account management and the changing healthcare landscape.”

Channel Liaison
Biogen

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head
BIOMERIEUX

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead
Genentech

About the Conference:

As medical device manufacturers navigate the changing industry landscape throughout the implementation of the European Medical Device Regulation, one of the most pressing requirements facing clinical research executives is the enhancement of post-market clinical follow-up, surveillance, and reporting strategies. Placing a major focus on real-world evidence, the MDR presents professionals in clinical research with numerous challenges as they seek to provide an accurate representation of each device’s performance and safety once on the market. While the volume and sources of data required by competent authorities and notified bodies to support each device’s continued market presence are in some cases still uncertain, leaders in the field recognize the urgency of developing and implementing compliant plans for the collection of relevant and sufficient data while working to contain costs.

Core Topics to be Addressed

  • Defining the level of clinical evidence deemed sufficient under MDR
  • Proactively aggregating a body of evidence to meet PMCF requirements
  • Examination of various cost-effective data gathering methodologies
  • Optimizing the cohesive reporting of PMCF, PMSF & clinical evaluation data
  • Aligning internal teams during development & implementation PMCF plans

Program Highlights:

  • Insight into practical solutions for optimizing PMCF plans
  • Engaging workshops & small group discussions
  • Focus on knowledge-share & participatory learning

Core Topics to be Addressed

  • Defining the level of clinical evidence deemed sufficient under MDR
  • Proactively aggregating a body of evidence to meet PMCF requirements
  • Examination of various cost-effective data gathering methodologies
  • Optimizing the cohesive reporting of PMCF, PMSF & clinical evaluation data
  • Aligning internal teams during development & implementation PMCF plans

Request Invite

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

Audience

75 Attendees

All attendees come directly from medical device companies

Distinguished Presenters

Speaker recruitment in progress

Networking

Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This